R&G PharmaStudies Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
2,645
- Stock Symbol
-
301333
- Investments
-
1
- Share Price
-
$7.95
- (As of Friday Closing)
R&G PharmaStudies General Information
Description
R&G PharmaStudies Co Ltd is a clinical trial outsourcing service provider. It offers full-chain clinical research outsourcing services, serving global pharmaceutical and medical device companies and scientific research institutions.
Contact Information
Website
www.rg-pharma.comCorporate Office
- 11th Floor, North Tower, Block B Huatong Building
- No. 19, Chegongzhuang West Road Haidian District
- Beijing, 100048
- China
Corporate Office
- 11th Floor, North Tower, Block B Huatong Building
- No. 19, Chegongzhuang West Road Haidian District
- Beijing, 100048
- China
R&G PharmaStudies Stock Performance
As of 13-Nov-2026, R&G PharmaStudies’s stock price is $7.95. Its current market cap is $768M with 96.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.95 | $8.28 | $6.47 - $13.15 | $768M | 96.6M | 2.78M | $0.18 |
R&G PharmaStudies Financials Summary
As of 30-Sep-2026, R&G PharmaStudies has a trailing 12-month revenue of $139M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 718,686 | 583,456 | 437,817 | 642,037 |
| Revenue | 138,904 | 118,338 | 103,687 | 101,963 |
| EBITDA | 17,350 | 25,380 | 26,205 | 29,189 |
| Net Income | 16,904 | 19,037 | 19,542 | 22,973 |
| Total Assets | 360,922 | 342,966 | 320,026 | 292,557 |
| Total Debt | 7,471 | 6,364 | 13,495 | 1,251 |
R&G PharmaStudies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
R&G PharmaStudies Signals
R&G PharmaStudies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
R&G PharmaStudies Investments (1)
R&G PharmaStudies’s most recent deal was a Early Stage VC with Genfleet for . The deal was made on 30-Mar-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Genfleet | 30-Mar-2020 | Early Stage VC | Drug Discovery |
R&G PharmaStudies ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
R&G PharmaStudies Exits (1)
R&G PharmaStudies’s most recent exit was on 30-Mar-2020 from Genfleet. The exit was categorized as with 11 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Genfleet | 30-Mar-2020 | Completed |
|
R&G PharmaStudies FAQs
-
When was R&G PharmaStudies founded?
R&G PharmaStudies was founded in 2008.
-
Where is R&G PharmaStudies headquartered?
R&G PharmaStudies is headquartered in Beijing, China.
-
What is the size of R&G PharmaStudies?
R&G PharmaStudies has 2,645 total employees.
-
What industry is R&G PharmaStudies in?
R&G PharmaStudies’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is R&G PharmaStudies a private or public company?
R&G PharmaStudies is a Public company.
-
What is R&G PharmaStudies’s stock symbol?
The ticker symbol for R&G PharmaStudies is 301333.
-
What is the current stock price of R&G PharmaStudies?
As of 13-Nov-2026 the stock price of R&G PharmaStudies is $7.95.
-
What is the current market cap of R&G PharmaStudies?
The current market capitalization of R&G PharmaStudies is $768M.
-
What is R&G PharmaStudies’s current revenue?
The trailing twelve month revenue for R&G PharmaStudies is $139M.
-
What is R&G PharmaStudies’s annual earnings per share (EPS)?
R&G PharmaStudies’s EPS for 12 months was $0.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process